The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein–ubiquitin ligase SCFSkp2

  1. Donato Tedesco1,
  2. Jiri Lukas2, and
  3. Steven I. Reed1,3
  1. 1Department of Molecular Biology, MB-7, The Scripps Research Institute, La Jolla, California 92037, USA; 2Danish Cancer Society, Institute of Cancer Biology, DK-2100 Copenhagen O, Denmark

Abstract

p130 is a tumor suppressor of the pocket protein family whose expression is posttranscriptionally regulated and largely G0 restricted. The mechanism of down-regulation of p130 expression in proliferating cells was investigated. Our results indicate that the decline of p130 expression as G0 cells reenter the cell cycle is due to a decrease in protein stability. The enhancement of p130 turnover in late G1 and S phase compared with G0 and early G1 phase was dependent on Cdk4/6-specific phosphorylation of p130 on Serine 672, and independent of Cdk2 activity. The activity of the ubiquitin ligase complex Skp1–Cul1/Cdc53–F-box protein Skp2 (SCFSkp2) and the proteasome were necessary for p130 degradation. In vitro, recombinant Skp2 was able to bind hyperphosphorylated but not dephosphorylated p130. Furthermore, in vitro polyubiquitination of p130 by SCFSkp2 was specifically dependent on phosphorylation of p130 on Serine 672. Thus, like the Cdk inhibitor p27Kip1, p130 turnover is regulated by Cdk-dependent G1 phosphorylation leading to ubiquitin-dependent proteolysis.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL sreed{at}scripps.edu; FAX (858) 784-2781.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1011202.

    • Received May 30, 2002.
    • Accepted September 25, 2002.
| Table of Contents

Life Science Alliance